The milestone, announced August 5, 2026, highlights the effectiveness of the strategy employed by B.I. Sky Global Ltd., the consumer wellness subsidiary through which Innocan operates. By focusing on targeted online sales channels, the company has managed to scale its footprint despite the crowded landscape of American beauty and self-care retail. Roni Kamhi, CEO of B.I. Sky Global and COO of Innocan, described the volume of feedback as a validation of the company's customer-first approach. According to the firm, the data reflects consistent product quality and rising loyalty among American shoppers. Innocan continues to leverage this momentum to drive its long-term growth, balancing its pharmaceutical research with high-performance skincare offerings.
Innocan Pharma Brand Hits 100,000 Verified Reviews Milestone
More than 100,000 positive verified reviews have been logged for Valitic, the flagship skincare line under Innocan Pharma Corporation. This achievement marks a significant expansion for the company within the competitive U.S. wellness market, signaling a shift in consumer sentiment toward the brand’s digital-first product portfolio.
Comments (0)
No comments yet. Be the first!